Pharmaceutical companies are moving forward to raise funds… Handok’s purpose is ‘Debt Repayment’

Published: 2014-10-31 13:27:13

Updated: 2014-10-31 13:34:32

There have been continuous actions to raise funds among domestic pharmaceutical companies in Korea. While Hanmi Pharmaceutical recapitalized KRW 100 billion to secure funds for R&D last year, Daewoong Pharmaceutical recently decided to issue company stocks worth of KRW 100 billion to raise funds to construct the Osong factory. Handok will also issue company stocks worth of KRW 30 billion.

Howe...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.